Anders Lönneborg

Summary

Publications

  1. doi request reprint A novel blood test for the early detection of Alzheimer's disease
    Phil D Rye
    DiaGenic ASA, Oslo, Norway
    J Alzheimers Dis 23:121-9. 2011
  2. ncbi request reprint Biomarkers for Alzheimer disease in cerebrospinal fluid, urine, and blood
    Anders Lönneborg
    DiaGenic ASA, Oslo, Norway
    Mol Diagn Ther 12:307-20. 2008
  3. doi request reprint Prediction of mild cognitive impairment that evolves into Alzheimer's disease dementia within two years using a gene expression signature in blood: a pilot study
    Line Roed
    DiaGenic ASA, Grenseveien 92, Oslo, Norway
    J Alzheimers Dis 35:611-21. 2013
  4. doi request reprint Found in transcription: accurate Parkinson's disease classification in peripheral blood
    Magdalena Kauczynska Karlsson
    DiaGenic ASA, Oslo, Norway
    J Parkinsons Dis 3:19-29. 2013

Collaborators

  • Praveen Sharma
  • Magnus Sjogren
  • Mala Naik
  • Magdalena Kauczynska Karlsson
  • Line Roed
  • Torbjørn Lindahl
  • Gisle Grave
  • Christer Nilsson
  • Peter O Horndalsveen
  • Phil D Rye
  • Jan Aasly
  • Frank Swenson
  • Orjan Skogar
  • Lars Lannfelt
  • Edith Rian
  • Mathias Toft
  • Solve Sæbø
  • Hilde Marie Andersen
  • Lena Kristiansen
  • Dag Aarsland
  • Peter Wetterberg
  • Birgitte Boonstra Booij
  • Harald A Nygaard
  • Dagne Hoprekstad

Detail Information

Publications4

  1. doi request reprint A novel blood test for the early detection of Alzheimer's disease
    Phil D Rye
    DiaGenic ASA, Oslo, Norway
    J Alzheimers Dis 23:121-9. 2011
    ..These findings suggest that the gene expression blood test can aid in the diagnosis of mild to moderate AD, but further studies are needed to confirm these findings...
  2. ncbi request reprint Biomarkers for Alzheimer disease in cerebrospinal fluid, urine, and blood
    Anders Lönneborg
    DiaGenic ASA, Oslo, Norway
    Mol Diagn Ther 12:307-20. 2008
    ..The plethora of potential biomarkers currently being investigated may soon provide biomarkers that fulfill different functions, not only for diagnostic purposes but also for drug development and to follow disease progression...
  3. doi request reprint Prediction of mild cognitive impairment that evolves into Alzheimer's disease dementia within two years using a gene expression signature in blood: a pilot study
    Line Roed
    DiaGenic ASA, Grenseveien 92, Oslo, Norway
    J Alzheimers Dis 35:611-21. 2013
    ..For development of disease-modifying drugs, a reliable and accurate test for identification of mild cognitive impairment (MCI) due to AD is essential...
  4. doi request reprint Found in transcription: accurate Parkinson's disease classification in peripheral blood
    Magdalena Kauczynska Karlsson
    DiaGenic ASA, Oslo, Norway
    J Parkinsons Dis 3:19-29. 2013
    ..Conclusions: PD affects gene expression in blood, suggesting the potential for the development of a blood-based gene expression test. ..